{"id":1048858,"date":"2012-10-10T12:15:49","date_gmt":"2012-10-10T12:15:49","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/uncategorized\/cell-receptor-research-wins-americans-chemistry-nobel.php"},"modified":"2024-08-17T17:59:20","modified_gmt":"2024-08-17T21:59:20","slug":"cell-receptor-research-wins-americans-chemistry-nobel","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/chemistry\/cell-receptor-research-wins-americans-chemistry-nobel.php","title":{"rendered":"Cell receptor research wins Americans chemistry Nobel"},"content":{"rendered":"<p><p>    STOCKHOLM (Reuters) - Two American scientists won the 2012    Nobel Prize for    chemistry on Wednesday for research into how cells    respond to external stimuli that is helping to develop better    drugs to fight diseases such as diabetes, cancer and    depression.  <\/p>\n<p>    The Royal Swedish    Academy of Sciences said the 8 million crown ($1.2    million) prize went to Robert Lefkowitz, 69, and Brian Kobilka, 57, for    discovering the inner workings of G-protein-coupled receptors,    which allow cells to respond to chemical messages such as    adrenaline rushes.  <\/p>\n<p>    \"Around half of all medications act through these receptors,    among them beta blockers, antihistamines and various kinds of    psychiatric    medications,\" the committee said.  <\/p>\n<p>    Working out better ways to target the receptors, known as    GPCRs, is an area of keen focus for pharmaceutical and    biotechnology companies.  <\/p>\n<p>    Lefkowitz told a news conference by telephone he was asleep    when the phone call came from Sweden.  <\/p>\n<p>    \"I did not hear it - I must share with you that I wear earplugs    to sleep. So my wife gave me an elbow. So there it was, a total    shock and surprise,\" he said.  <\/p>\n<p>    Sven Lidin, Professor of Inorganic Chemistry at Lund University    and chairman of the committee, told a news conference the    discovery had been key in medical research.  <\/p>\n<p>    \"Knowing what they (the receptors) look like and how they    function will provide us with the tools to make better drugs    with fewer side effects,\" he added.  <\/p>\n<p>    GPCRs are linked to a wide range of diseases, since they play a    central role in many biological functions in the body, but    developing new drugs to target them accurately has been    difficult because of a lack of fundamental understanding as to    how they function. Experts say the work of the Nobel Prize winners    has opened the door to making better medicines.  <\/p>\n<p>    Drugs targeting GPCRs have potential in treating illnesses    involving the central nervous system, heart conditions,    inflammation and metabolic disorders.  <\/p>\n<\/p>\n<p>Continued here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/news.yahoo.com\/cell-receptor-wins-nobel-prize-chemistry-095649389.html;_ylt=A2KJNF_rZnVQG00AGK3_wgt.\" title=\"Cell receptor research wins Americans chemistry Nobel\" rel=\"noopener\">Cell receptor research wins Americans chemistry Nobel<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> STOCKHOLM (Reuters) - Two American scientists won the 2012 Nobel Prize for chemistry on Wednesday for research into how cells respond to external stimuli that is helping to develop better drugs to fight diseases such as diabetes, cancer and depression. The Royal Swedish Academy of Sciences said the 8 million crown ($1.2 million) prize went to Robert Lefkowitz, 69, and Brian Kobilka, 57, for discovering the inner workings of G-protein-coupled receptors, which allow cells to respond to chemical messages such as adrenaline rushes.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/chemistry\/cell-receptor-research-wins-americans-chemistry-nobel.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246863],"tags":[],"class_list":["post-1048858","post","type-post","status-publish","format-standard","hentry","category-chemistry"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1048858"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1048858"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1048858\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1048858"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1048858"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1048858"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}